The Extracellular N-terminal Domain of G-protein Coupled Receptor 83 Regulates Signaling Properties and is an Intramolecular Inverse Agonist
Overview
General Medicine
Authors
Affiliations
Background: Recently, the orphan G-protein coupled receptor 83 (GPR83) was identified as a new participant in body weight regulation. This receptor is highly expressed in the hypothalamic arcuate nucleus and is regulated in response to nutrient availability. Gpr83 knock-out mice are protected from diet-induced obesity. Moreover, in a previous study, we designed and characterized several artificial constitutively activating mutations (CAMs) in GPR83. A particular CAM was located in the extracellular N-terminal domain (eNDo) that is highly conserved among GPR83 orthologs. This suggests the contribution of this receptor part into regulation of signaling, which needed a more detailed investigation.
Findings: In this present study, therefore, we further explored the role of the eNDo in regulating GPR83-signaling and demonstrate a proof-of-principle approach in that deletion mutants are characterized by a strong increase in basal Gq/11-mediated signaling, whilst none of the additionally characterized signaling pathways (Gs, Gi, G12/13) were activated by the N-terminal deletion variants. Of note, we detected basal GPR83 MAPK-activity of the wild type receptor, which was not increased in the deletion variants.
Conclusions: Finally, the extracellular portion of GPR83 has a strong regulatory function on this receptor. A suppressive - inverse agonistic - effect of the eNDo on GPR83 signaling activity is demonstrated here, which also suggests a putative link between extracellular receptor activation and proteolytic cleavage. These new insights highlight important aspects of GPR83-regulation and might open options in the development of tools to modulate GPR83-signaling.
Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and Regulation.
Mack S, Gomes I, Devi L ACS Chem Neurosci. 2019; 10(4):1884-1891.
PMID: 30726666 PMC: 6996248. DOI: 10.1021/acschemneuro.8b00559.
Shey R, Ghogomu S, Njume F, Gainkam L, Poelvoorde P, Mutesa L PLoS One. 2018; 13(9):e0202915.
PMID: 30256790 PMC: 6157839. DOI: 10.1371/journal.pone.0202915.
Orphan neuropeptides and receptors: Novel therapeutic targets.
Fricker L, Devi L Pharmacol Ther. 2017; 185:26-33.
PMID: 29174650 PMC: 5899030. DOI: 10.1016/j.pharmthera.2017.11.006.
Muller A, Berkmann J, Scheerer P, Biebermann H, Kleinau G PLoS One. 2016; 11(12):e0168260.
PMID: 27936173 PMC: 5148169. DOI: 10.1371/journal.pone.0168260.
Identification of GPR83 as the receptor for the neuroendocrine peptide PEN.
Gomes I, Bobeck E, Margolis E, Gupta A, Sierra S, Fakira A Sci Signal. 2016; 9(425):ra43.
PMID: 27117253 PMC: 5147544. DOI: 10.1126/scisignal.aad0694.